Related Experiment Videos
[Circulation immune complexes in chronic glomerulonephritis].
Summary
Elevated levels of circulating immune complexes were detected in patients with lupus nephritis and chronic glomerulonephritis. This finding suggests immune complex determination is valuable for diagnosing kidney diseases.
Area of Science:
- Nephrology
- Immunology
- Clinical Chemistry
Background:
- Chronic kidney diseases, including chronic glomerulonephritis and lupus nephritis, are significant health concerns.
- Circulating immune complexes (CICs) are implicated in the pathogenesis of various autoimmune and kidney diseases.
- Accurate detection of CICs is crucial for diagnosis and monitoring of renal conditions.
Purpose of the Study:
- To determine the levels of circulating immune complexes in patients with chronic glomerulonephritis and lupus nephritis.
- To compare CIC levels between patients with different kidney diseases and healthy individuals.
- To assess the diagnostic utility of CIC measurement in renal pathology.
Main Methods:
- Polyethylene glycol (PEG) precipitation method was employed for CIC determination.
- Study included 36 patients with chronic glomerulonephritis, 5 with lupus nephritis, 35 with chronic pyelonephritis, and 60 healthy controls.
- Normal CIC levels in healthy subjects were established (mean + 2 standard deviations = 0.217 mg/ml).
Main Results:
- Elevated CIC levels were observed in 60% of lupus nephritis patients (mean 0.475 +/- 0.554 mg/ml) and 25% of chronic glomerulonephritis patients (mean 0.184 +/- 0.185 mg/ml).
- Patients with lupus nephritis showed significantly higher CIC levels, often exceeding the normal range.
- Patients with chronic glomerulonephritis frequently had CIC levels at the upper limit of the normal range.
Conclusions:
- Circulating immune complexes are frequently elevated in patients with lupus nephritis and chronic glomerulonephritis.
- PEG precipitation is a useful method for detecting elevated CICs in patients with kidney diseases.
- CIC levels may serve as a biomarker for disease activity and severity in certain nephropathies.